StrokeFlow Empowering physicians to provide every stroke treatment with the right treatment in time, with StrokeFlow
- Coordinator
- Nico-Lab BV, Netherlands
- Runs
- 1 March 2023 to 28 February 2025
- Status
- Running
- EU funding
- €2.2m
- Total cost
- €3.2m
- Partners
- 1 organisations in 1 countries
- Type
- European Innovation Council
- Grant agreement
- 190148118
What the project is doing
In the project's own words, from its summary on CORDIS.
Stroke patients represent the most time critical field of emergency medicine. Every minute counts when it comes to stroke – every minute delay in treatment leads to 22 healthy days lost. No comprehensive solution exists that solves the life-threatening bottlenecks in the complex stroke acute care chain, resulting in 1/3 of patients dead and 1/3 becoming disabled. The main challenge is that stroke care specialists are essentially “treating in the dark”.
They lack the speed to share accurate patient data in real-time with colleagues, and they have no readily accessible information at all about the blood clot causing the stroke. All stroke patients are inevitably treated ineffectively in a “one size fits all” approach as physicians “go in blind” every intervention. It is our mission to empower physicians to treat every stroke patient in time with the right treatment. With StrokeFlow, we for the first time enable this with ground-breaking technology and innovative solutions.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Nico-Lab BV | Amsterdam | Netherlands | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI